Navigation Links
Study Pinpoints Optimal Treatment Window for HIV
Date:1/16/2013

WEDNESDAY, Jan. 16 (HealthDay News) -- A new study shows the advantage of beginning antiretroviral therapy within four months of infection with HIV, the virus that causes AIDS.

Researchers analyzed data from nearly 500 patients infected with HIV-1 and found that those who began antiretroviral therapy within four months of their infection date -- and had higher CD4+ T-cell counts at the start of therapy -- had a stronger recovery of key CD4+ T-cell counts than those who began treatment later.

Normal CD4+ T-cell counts were restored in 64 percent of patients who began antiretroviral therapy within four months of infection, compared with 34 percent of patients who began treatment later.

CD4+ T-cells -- specialized immune cells that fight infections -- are depleted in people with HIV, the researchers said. In the four months after a person is infected with HIV, the immune system tries to boost levels of CD4+ T-cells. After this temporary increase, levels of the cells begin to decline, explained the authors of the study, which was published Jan. 17 in the New England Journal of Medicine.

"This study suggests greater urgency to start antiretroviral therapy earlier, when the most weapons in the immunity armamentarium are at the body's disposal," co-lead author Dr. Sunil Ahuja, a professor of medicine, microbiology/immunology and biochemistry in the School of Medicine at the University of Texas Health Science Center at San Antonio, said in a center news release.

Ahuja also is director of the Veterans Administration Center for AIDS and HIV Infection, a national center within the South Texas Veterans Health Care System.

Other experts agreed that the study points to the importance of early treatment.

"The question of when to begin [antiretroviral therapy] remains a difficult one," but this study and others provide strong supportive evidence suggesting a benefit for early therapy, Dr. Bruce Walker and Dr. Martin Hirsch, of Harvard Medical School, wrote in an accompanying journal editorial.

More information

AIDS.gov has more about CD4 cell count.

-- Robert Preidt

SOURCE: University of Texas Health Science Center at San Antonio, news release, Jan. 16, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Fetal Deaths Up Among Unvaccinated Moms in H1N1 Pandemic: Study
2. Smartphone Apps for Skin Cancer Risk Arent Reliable, Study Finds
3. As Parents Share of College Fees Rises, Students GPAs Fall: Study
4. Breast Cancer Message Board study finds frequent discussion of drug side effects, stopping therapy
5. U of T and Harvard study finds growing weight extremes in the developing world
6. Study examines link between incarceration and psychiatric disorders
7. Blood Clots During Pregnancy More Likely After IVF, Study Says
8. New SMU-North Texas food bank study to analyze causes of hunger in North Texas
9. Unneeded Antibiotics May Lead to Diarrheal Illness, Study Finds
10. Study Finds Low Flu Vaccine Rates in U.S. Kids
11. Kaiser Permanente study: Change in PSA levels over time can help predict aggressive prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study Pinpoints Optimal Treatment Window for HIV
(Date:2/24/2017)... ... February 24, 2017 , ... The Radiology Business Management Association ... marketing programs at the annual Building Better Radiology Marketing Programs conference, held ... in Fort Worth, Texas. Nine awards are given out in five categories. They are:, ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... ... in Charlevoix, once again hosted their Military Wedding Giveaway, with the winning couple ... by Castle Farms with services generously donated from local vendors: A Matter of ...
(Date:2/23/2017)... CO (PRWEB) , ... February 23, 2017 , ... The ... announce the winner of the 2016 National Education Policy Center Bunkum Award. We invite ... reviewed in 2016. , This year’s Bunkum winner is the Center for American Progress ...
(Date:2/23/2017)... ... February 23, 2017 , ... The American Cleft Palate-Craniofacial Association (ACPA) is pleased ... KLS is a longtime supporter of the event. , "We are pleased that KLS ... Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has a long track record of ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... , media relations, content marketing, social media management, corporate communications, SEO and cause ... the state and in nearby New Hampshire, Massachusetts and Canada, Rosica will focus ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... -- Im Rahmen seiner Schlüsselwachstumsstrategie arbeitet die ... chinesischen Provinz Guizhou, 2017 mit dem Angebot von Anreize schaffenden ... Entwicklung einer eingebetteten Hightech-Schlüsselindustrie. Foto - http://mma.prnewswire.com/media/471342/First_CRH__CHina_Railway_High_Speed__Train_Enters_Guian.jpg ... ... ...
(Date:2/23/2017)... Research and Markets has announced the addition ... report to their offering. ... The latest research Fibromyalgia Drugs Price Analysis and ... global Fibromyalgia market. The research answers the following questions: ... Fibromyalgia and their clinical attributes? How are they positioned in the ...
(Date:2/23/2017)... Regulus Therapeutics Inc . (Nasdaq: RGLS), ... innovative medicines targeting microRNAs, today announced it will release ... Thursday, March 2, 2017 after the market closes. ... on March 2, 2017 at 5:00 p.m. Eastern Time ... results and provide a general business update.  A live ...
Breaking Medicine Technology: